5% Dextrose Injection USP — Class I drug recall D-0094-2017
Terminated recall by B. Braun Medical Inc, reported 2016-10-19, distributed nationwide. Non-Sterility: fungal contamination due to leaking containers.
| Recall number | D-0094-2017 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | B. Braun Medical Inc, Irvine, CA, United States |
| Recall initiated | 2016-03-25 |
| Classified | 2016-10-12 |
| Reported by FDA | 2016-10-19 |
| Terminated | 2016-10-12 |
| Distributed | Nationwide (US) |
| Quantity | 57,408 units |
| Reason classes | microbial contamination, sterility, packaging |
| Pathogens | mold |
| NDC | 00264-1510-32 |
| Lot numbers | J5J706 |
| Expiration dates | 2016-10-31 |
Product
5% Dextrose Injection USP, 100mL in a 150 mL PAB container, Rx only, B. Braun Medical Inc. Irvine, CA 92614-5895 USA, NDC 00264-1510-32
Reason for recall
Non-Sterility: fungal contamination due to leaking containers.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0094-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.